Vivos Therapeutics (NASDAQ:VVOS) versus West Pharmaceutical Services (NYSE:WST) Head-To-Head Review

Vivos Therapeutics (NASDAQ:VVOS) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent ratings for Vivos Therapeutics and West Pharmaceutical Services, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivos Therapeutics	1	1	2	0	2.25
West Pharmaceutical Services	0	1	13	0	2.93

Vivos Therapeutics currently has a consensus price target of $2.80, suggesting a potential upside of 3,144.50%. West Pharmaceutical Services has a consensus price target of $424.67, suggesting a potential upside of 2.96%. Given Vivos Therapeutics’ higher probable upside, research analysts plainly believe Vivos Therapeutics is more favorable than West Pharmaceutical Services.

Risk and Volatility

Vivos Therapeutics has a beta of 6.37, meaning that its stock price is 537% more volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.

Earnings and Valuation

This table compares Vivos Therapeutics and West Pharmaceutical Services”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivos Therapeutics	$17.44 million	0.07	-$21.17 million	($1.90)	-0.05
West Pharmaceutical Services	$3.07 billion	9.35	$493.70 million	$8.91	46.29

West Pharmaceutical Services has higher revenue and earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

26.4% of Vivos Therapeutics shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 1.4% of Vivos Therapeutics shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Vivos Therapeutics and West Pharmaceutical Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivos Therapeutics	-122.00%	-2,325.64%	-102.01%
West Pharmaceutical Services	18.81%	21.78%	15.99%

Summary

West Pharmaceutical Services beats Vivos Therapeutics on 11 of the 14 factors compared between the two stocks.

About Vivos Therapeutics

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing oral appliances and related treatments for sleep-disordered breathing, including obstructive sleep apnea (OSA) and snoring. Its approach is designed to help improve upper-airway function through non-surgical, dentist-supervised therapies. The company’s primary products are its Vivos Complete Airway Repositioning and Expansion (CARE) oral appliances, which are customized for individual patients and intended for use during sleep.

About West Pharmaceutical Services

West Pharmaceutical Services designs and manufactures packaging components and delivery systems used by the pharmaceutical, biotechnology, and medical device industries. Its products help contain and administer injectable medicines and include elastomeric components, such as stoppers and seals, as well as syringe components and other packaging and delivery solutions. The company also provides contract manufacturing services for medical devices and pharmaceutical delivery systems. Its customers include companies developing and producing branded, generic, and biologic medicines.